Cutler Group LP Caladrius Biosciences, Inc. Call Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
About CALADRIUS BIOSCIENCES, INC.
- Ticker CLBS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,583,200
- Market Cap $25.8M
- Description
- Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...